EE198 Cost-Effectiveness of Sacubitril/Valsartan for the Treatment of Essential Hypertension in Chinese Setting
Jul 1, 2022, 00:00 AM
10.1016/j.jval.2022.04.447
https://www.valueinhealthjournal.com/article/S1098-3015(22)00648-9/fulltext
Section Title :
Section Order :
10395
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00648-9&doi=10.1016/j.jval.2022.04.447